Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma
What is the purpose of this trial?
This randomized phase III trial is studying combination chemotherapy in treating patients with non-metastatic extracranial Ewing sarcoma. Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells.
- Up to 50 Years
- Children's Oncology Group (The)
National Cancer Institute (NCI)
- Last Updated:
- Study HIC#: